Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
BCMA-directed therapy with cizutamig induces rapid improvement in long-standing systemic sclerosis-associated interstitial lung disease.
Journal: Rheumatology (Oxford, England)
Published: June 23, 2026
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: January 18, 2021
A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: June 26, 2020
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772).
Journal: The European respiratory journal
Published: June 15, 2018
Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenon.
Journal: Arthritis care & research
Published: January 26, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026